Adjunctive hyperbaric oxygen treatment for challenging pyoderma gangrenosum cases.
Alternative therapies
Healing
Hyperbaric oxygen therapy
Neutrophilic dermatoses
Pyoderma gangrenosum
Ulcers
Journal
Journal of tissue viability
ISSN: 0965-206X
Titre abrégé: J Tissue Viability
Pays: England
ID NLM: 9306822
Informations de publication
Date de publication:
05 Jun 2024
05 Jun 2024
Historique:
received:
31
10
2023
revised:
08
04
2024
accepted:
05
06
2024
medline:
9
6
2024
pubmed:
9
6
2024
entrez:
9
6
2024
Statut:
aheadofprint
Résumé
Pyoderma gangrenosum (PG) is a rare, difficult-to-treat neutrophilic ulcerative cutaneous condition that severely impacts those affected. Treatment options for PG are limited, and disease remission is not guaranteed. Hyperbaric oxygen treatment is a potential therapeutic option for treating various ulcerative conditions not frequently utilized for PG. We present a case of a patient with treatment-resistant PG who achieved remission with adjunctive HBOT, and then later had difficulty achieving remission without HBOT during a future flare. HBOT should be more readily considered as a treatment option for those with PG.
Identifiants
pubmed: 38851917
pii: S0965-206X(24)00076-7
doi: 10.1016/j.jtv.2024.06.001
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All authors have no relevant conflicts of interest to declare.